At NovaKart Retail a lead data scientist must deliver a production grade generative AI application that will fine tune a foundation model on about 28 TB of proprietary product and support documents ...

Learn how to append text to files in Linux using commands like double redirection operator, tee, and sed without overwriting existing data.

Looking to unlock deeper data-driven insights or to build more intelligent business process automations? These popular tools ...

Discover how backend engineering has evolved in 2025, including AI integration, real-time data, and essential skills for ...

Introduction We present an automatic and scalable text-to-SQL data synthesis framework, illustrated below: Based on this framework, we introduce the first million-scale text-to-SQL dataset, ...

Espresso AI, the LLM-driven optimization platform for data warehouses, today launched a new solution that turns Databricks into an agentic lakehouse. Espresso AI was founded by ex-Googlers who worked ...

If you want to pass the GH-300 GitHub Copilot Certification exam on your first attempt, you not only need to learn the exam material, but also master how to analyze and answer GitHub Copilot exam ...

Ansell Ltd reported an unauthorised access to company data due to third-party software vulnerabilities, with no impact on daily operations and immediate containment measures initiated. The breach was ...

The BLS will release key inflation data despite the government shutdown A recent estimate projected the 2026 Social Security COLA will be 2.7% That could change if the September inflation data brings ...

As of October 14, your Windows 10 PC has reached end of life (EOL.) Microsoft is ending mainstream support for Windows 10 after a decade on the market, and is encouraging all users to switch to ...

Auto news: While kangaroos and possums are a fixture on Australian roads, they're also a hazard. So, should you swerve to avoid wildlife? © 2025 Nine Entertainment Co.

HOUSTON, October 13, 2025--(BUSINESS WIRE)--Tvardi Therapeutics, Inc. ("Tvardi") (NASDAQ: TVRD), a clinical-stage biopharmaceutical company focused on the development of novel, oral, small molecule ...